Skip to main content
. 2013 Sep 15;1(1):33–38. doi: 10.14218/JCTH.2013.004XX

Figure 3. TAF is a new prodrug of tenofovir.

Figure 3

TDF and TAF are oral prodrugs of tenofovir. Both can be hydrolyzed in serum and are taken up into target cells. However, TAF is more efficient in delivering tenofovir into cells. TAF is more stable in the circulation allowing more efficient transport across cell membrane; it is more readily converted to tenofovir once inside target cells.47